A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603)

被引:57
作者
Gavin, Peter F. [1 ]
Olsen, Bernard A. [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Analyt Sci Res & Dev, Indianapolis, IN 46285 USA
关键词
liquid chromatography; ion-pairing; quality by design; system suitability; column equivalence; in situ degradation; atomoxetine;
D O I
10.1016/j.jpba.2007.10.037
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The development of an ion-pairing HPLC method and associated system suitability parameters for the analysis of atomoxetine hydrochloride (LY 139603 HCl) using a quality by design approach is described. Potential method conditions were evaluated for their ability to meet design requirements and statistically designed experiments were used to optimize conditions and demonstrate method robustness for the separation of atomoxetine and impurities. The separation of two early eluting impurities, phenyl methylaminopropanol (PMAP (+/-)3 -methyl amino-1-phenylpropanol) and mandelic acid is correlated to the separation of other impurities that elute near the main sample component and the resolution of this peak pair is used as a system suitability test without the need for impurity reference standards. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:431 / 441
页数:11
相关论文
共 22 条
[1]  
*COUNC EUR, 2007, EUR PHARM, P1104
[2]  
Department of Health and Human Services, 2004, PHARM CGMPS 21 CENTU
[3]   Choosing an equivalent replacement column for a reversed-phase liquid chromatographic assay procedure [J].
Dolan, JW ;
Maule, A ;
Bingley, D ;
Wrisley, L ;
Chan, CC ;
Angod, M ;
Lunte, C ;
Krisko, R ;
Winston, JM ;
Homeier, BA ;
McCalley, DV ;
Snyder, LR .
JOURNAL OF CHROMATOGRAPHY A, 2004, 1057 (1-2) :59-74
[4]   A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials [J].
Gavin, PF ;
Olsen, BA ;
Wirth, DD ;
Lorenz, KT .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (04) :1251-1259
[5]   Chemical and analytical characterization of related organic impurities in drugs [J].
Görög, S .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2003, 377 (05) :852-862
[6]  
Gorog S, 2000, IDENTIFICATION DETER, P772
[7]  
Meyer V., 1997, PITFALLS ERRORS HPLC, P56
[8]  
Olsen B.A., 2003, HDB ISOLATION CHARAC, P89
[9]   HPLC method development for duloxetine hydrochloride using a combination of computer-based solvent strength optimization and solvent selectivity mixture design [J].
Olsen, BA ;
Argentine, MD .
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 1996, 19 (12) :1993-2007
[10]   Advances in HPLC technology for the determination of drug impurities [J].
Olsen, Bernard A. ;
Castle, Bryan C. ;
Myers, David P. .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2006, 25 (08) :796-805